DCR-PH1

N/A

Report date: 2023/02/11 20:37:53
NME

Base Information

Drug NameDCR-PH1
Drug Alias NameDCR-PH1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceHydroxyacid oxidase 1 inhibitors
TargetsHydroxyacid oxidase 1
Therapy Area/IndicationsPrimary Hyperoxaluria Type 1Hyperoxaluria, Primary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDicerna Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDicerna Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPrimary Hyperoxaluria Type 1Hyperoxaluria, Primary

Other Information

ATC CodeN/A
Related LinksN/A